Skip to Page Content
Historical Archives
Collapse Childhood Obesity Treatment Approaches (ARCHIVES)
Sarah Armstrong, MD
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Description:

This presentation will review the current recommendations for screening and treatment of childhood obesity, including the efficacy of lifestyle-based treatment approaches. The issues related to pharmacotherapy and weight-loss surgery in adolescents will also be discussed.

 


Disclosures (at time of recording):

Speaker:

  • Sarah Armstong, MD: Nothing to disclose

Planners:

  • William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia

  • Craig Primack, MD, FACP, FOMA: Nestle: Speaker, Focus Group Member; VIVUS: Speaker, Consultant; Diet Owl Smart Phone Application: Founder

  • Nothing to Disclose: Michael Bateman, DO; Crystal Broussard, MD; Sandra Christensen, MSN, ARNP, FOMA; Krishna Doniparthi, MD, FOMA; Brent Gear, DO; Charles Halliman; Deborah Bade Horn, DO, MPH, MFOMA; Carl Knopke, MD; Richard Lindquist, MD, ABFM, FAASP, FOMA; Dana Mansell; Jeremy McConnell, MD, FOMA; Timothy McCormick, DO, MPH; Daisy Merey, MD, PhD; Scott Rigden, MD, FAAFP, MFOMA; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE, CPA; J. Warren Willey, DO

Formats Available: Streaming + MP4 Download
Original Presentation Date: June 26, 2017
On-Demand Release Date: Available Now
More InfoMore Info Childhood Obesity Treatment Approaches (ARCHIVES)
Collapse Dietary Treatment: Panel Discussion (ARCHIVES)
Michael Ozner, MD, FACC, FAHA; Krishna Doniparthi, MD, FOMA; and William S. Yancy Jr., MD, MHS
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.


Description:
This question and answer panel delves deeper into three diet types: the Mediterranean diet, a carbohydrate-restricted diet, and a vegetarian/vegan diet.

 


Disclosures (at time of recording):
Speakers:

  • Michael Ozner, MD, FACC, FAHA: Life Extension Foundation: Advisory Activities; Nordic Naturals: Advisory Activities 
  • Krishna Doniparthi, MD, FOMA: Nothing to disclose
  • William S. Yancy Jr., MD, MHS: Nothing to disclose 

Planners:

  • Nothing to Disclose: Marcie Gonzales; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Stacy Schmidt, PhD; Laurie Traetow, CAE
Formats Available: On-demand
Original Presentation Date: March 29, 2017
On-Demand Release Date: Available Now
More InfoMore Info Dietary Treatment: Panel Discussion (ARCHIVES)
Collapse GLP-1-based Therapies, a Viable Medical Treatment for Obesity? (ARCHIVES)
Barbara McGowan, MD, FRCP, PhD
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Description:
The incretin hormone GLP-1 acts as a satiety hormone, making it a potentially attractive target for the treatment of obesity. This lecture will discuss mechanisms by which GLP-1 affects satiety, review the efficacy of GLP-1-based therapies as weight loss agents in patients with type 2 diabetes, and include preliminary clinical trial data in patients without diabetes mellitus. The safety and current concerns surrounding this type of therapy will also be reviewed.


Disclosures (at time of recording):
Speaker:

  • Barbara McGowan, MD, FRCP, PhD: Novo Nordisk: Principal Investigator – SCALE Study and Administrative Board Member

Planners:

  • William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia
  • Craig Primack, MD, FACP, FOMA: Nestle: Speaker, Focus Group Member; VIVUS: Speaker, Consultant; Diet Owl Smart Phone Application: Founder
  • Eric Westman, MD, MHS, MFOMA: VIVUS, Inc.: National Advisory Board and Speaker’s Bureau; KE Diet: Scientific Advisory Board Member
  • Nothing to Disclose: Sandra Christensen, MSN, ARNP, FOMA; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Charles Halliman; Deborah Bade Horn, DO, MPH, MS, MFOMA; Carl Knopke, MD, FOMA; Dana Mansell; Jeremy McConnell, MD, FOMA; Timothy McCormick, DO, MPH; Daisy Merey, MD, PhD; Scott Rigden, MD, FAAFP, MFOMA; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE

 

Formats Available: On-demand
Original Presentation Date: March 29, 2017
On-Demand Release Date: Available Now
More InfoMore Info GLP-1-based Therapies, a Viable Medical Treatment for Obesity? (ARCHIVES)
Collapse Lipoprotein Pathology in Obesity (ARCHIVES)
Thomas Dayspring, MD, FACP, FNLA, NCMP
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Description:
Hyperlipidemia is an important risk factor for coronary heart disease. Dr. Dayspring will discuss the physiology of lipoprotein metabolism, emphasizing the role of triglycerides in creating apoB and apoA-I particles and the diagnosis of lipoprotein pathology typical of obese patients.


Disclosures (at time of recording):

Speaker:                                                 

  • Thomas Dayspring, MD, FACP, FNLA, NCMP: Health Diagnostic Lab: Consultant; GlaxoSmithKline: Lecture Bureau; Kowa Pharmaceuticals: Consultant

Planners:

  • William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia
  • Nothing to Disclose: Heidi Gordon, Dana Mansell; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE
Formats Available: On-demand
Original Presentation Date: July 11, 2017
On-Demand Release Date: Available Now
More InfoMore Info Lipoprotein Pathology in Obesity (ARCHIVES)
Collapse Medical Management of Diabetes during Weight Loss (ARCHIVES)
Carl Knopke, MD, FOMA; W. Allen Rader, MD, MFOMA; and Jeffrey Sicat, MD, FACE
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Description:

This session will address the management of diabetes during the weight-loss process. Drs. Knopke, Rader, and Sicat will each discuss actual case examples of how they manage type 1 and type 2 diabetes mellitus during patient weight loss, using two different treatment approaches: lifestyle changes or pharmacotherapy. The presenters will then answer attendee questions during a panel discussion.

 


Disclosures (at time of recording):

Speakers:

  • Carl Knopke, MD, FOMA: Nothing to disclose
  • W. Allen Rader, MD, MFOMA: Nothing to disclose
  • Jeffrey Sicat, MD, FACE: Eisai: Speakers Bureau; VIVUS: Speakers Bureau

Planners:

  • William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia

  • Craig Primack, MD, FACP, FOMA: Nestle: Speaker, Focus Group Member; VIVUS: Speaker, Consultant; Diet Owl Smart Phone Application: Founder

  • Nothing to Disclose: Michael Bateman, DO; Crystal Broussard, MD; Sandra Christensen, MSN, ARNP, FOMA; Krishna Doniparthi, MD, FOMA; Brent Gear, DO; Charles Halliman; Deborah Bade Horn, DO, MPH, MFOMA; Carl Knopke, MD, FOMA; Richard Lindquist, MD, ABFM, FAASP, FOMA; Dana Mansell; Jeremy McConnell, MD, FOMA; Timothy McCormick, DO, MPH; Daisy Merey, MD, PhD; Scott Rigden, MD, FAAFP, MFOMA; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE, CPA; J. Warren Willey, DO

Formats Available: On-demand
Original Presentation Date: August 21, 2017
On-Demand Release Date: Available Now
More InfoMore Info Medical Management of Diabetes during Weight Loss (ARCHIVES)
Collapse Metabolic and Bariatric Surgery - General Overview (ARCHIVES)
John Morton, MD, MPH, FACS, FASMBS
Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Disclosures (at time of recording):

Speaker:                                                 

  • John Morton, MD, MPH, FACS, FASMBS: Covidien (Speaker’s Bureau; Novo Nordisk: Speaker’s Bureau; Takeda: Speaker’s Bureau

Planners:

  • Nothing to Disclose: Dana Mansell, CHCP; William McCarthy, MD; Stacy Schmidt, PhD; Laurie Traetow, CAE

Originally Recorded: 10/1/2015

Formats Available: Streaming
Original Presentation Date: October 01, 2015
On-Demand Release Date: Available Now
More InfoMore Info Metabolic and Bariatric Surgery - General Overview (ARCHIVES)
Collapse The Eating Behavior Questionnaire: A Novel Clinical Examination (ARCHIVES)
Ed J. Hendricks, MD, MFOMA
Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Description:

Clinical and laboratory observations indicate that drug-induced weight loss is accompanied by significant changes in eating behavior. The Eating Behavior Questionnaire (EBQ)—a newly designed tool for measuring treatment-induced eating behavior change—will be presented and discussed during this lecture. Clinical data reveals that untreated patients have high EBQ scores, that treated patients have significantly lower EBQ scores, and that EBQ scores drop quickly and dramatically after treatment initiation.
 


Disclosures (at time of recording):

Speakers:

  • Ed J. Hendricks, MD, MFOMA: Eurodrug Laboraties: Speaker; Akrimax Pharmaceuticals: Speaker; VIVUS: Speaker: Citius Pharmaceuticals, LLC: Consultant; GLG Healthcare & Biomedical Council: Consultant

Planners:

  • William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia

  • Craig Primack, MD, FACP, FOMA: Nestle: Speaker, Focus Group Member; VIVUS: Speaker, Consultant; Diet Owl Smart Phone Application: Founder

  • Nothing to Disclose: Michael Bateman, DO; Crystal Broussard, MD; Sandra Christensen, MSN, ARNP, FOMA; Krishna Doniparthi, MD, FOMA; Brent Gear, DO; Charles Halliman; Deborah Bade Horn, DO, MPH, MFOMA; Carl Knopke, MD, FOMA; Richard Lindquist, MD, ABFM, FAASP, FOMA; Dana Mansell; Jeremy McConnell, MD, FOMA; Timothy McCormick, DO, MPH; Daisy Merey, MD, PhD; Scott Rigden, MD, FAAFP, MFOMA; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE, CPA; J. Warren Willey, DO

Formats Available: On-demand
Original Presentation Date: June 20, 2017
On-Demand Release Date: Available Now
More InfoMore Info The Eating Behavior Questionnaire: A Novel Clinical Examination (ARCHIVES)
Collapse The Sugar Pandemic: Policy Versus Politics (ARCHIVES)
Robert Lustig, MD, MSL
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Description:
Sugar's potential for abuse, coupled with its toxicity and pervasiveness in the western diet, make it a primary culprit of the obesity epidemic. Sugar changes metabolism, raises blood pressure, critically alters the signaling of hormones and causes significant damage to the liver. This presentation will make the case for sugar to be controlled like alcohol and tobacco to protect public health.

 


Disclosures (at time of recording):
Speaker:

  • Robert Lustig, MD, MSL: Nothing to disclose

Planners:

  • William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia
  • Craig Primack, MD, FACP, FOMA: Nestle: Speaker, Focus Group Member; VIVUS: Speaker, Consultant; Diet Owl Smart Phone Application: Founder
  • Eric Westman, MD, MHS, MFOMA: VIVUS, Inc.: National Advisory Board and Speaker’s Bureau; KE Diet: Scientific Advisory Board Member
  • Nothing to Disclose: Sandra Christensen, MSN, ARNP, FOMA; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Charles Halliman; Deborah Bade Horn, DO, MPH, MS, MFOMA; Carl Knopke, MD, FOMA; Dana Mansell; Jeremy McConnell, MD, FOMA; Timothy McCormick, DO, MPH; Daisy Merey, MD, PhD; Scott Rigden, MD, FAAFP, MFOMA; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE

 

Formats Available: On-demand
Original Presentation Date: March 21, 2017
On-Demand Release Date: Available Now
More InfoMore Info The Sugar Pandemic: Policy Versus Politics (ARCHIVES)
Collapse Treatment of Diabetes (Part 4): Panel Discussion (ARCHIVES)
John Foreyt, PhD, Kevin C. Maki, PhD, CLS, FNLA, FTOS, and William S. Yancy, Jr., MD, MHS

 

*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Description:

The panel will deliberate about the benefits of using a low-carbohydrate or low-fat approach for diabetes treatment.

 


Disclosures (at time of recording):  
Speakers:

  • John Foreyt, PhD: Nothing to disclose

  • Kevin C. Maki, PhD, CLS, FNLA, FTOS: Kellogg: Advisory Board and Research; National Dairy Council: Advisory Board and Research; American Egg Board: Advisory Board and Research; National Cattleman’s Beef Association: Advisory Board and Research; Biofortis: Advisory Board

  • William S. Yancy, Jr., MD, MHS: NutriSystem: Advisory Board; Weight Watchers: Research; ViiV Healthcare: Spouse Part-time Employment

Planners:

  • Eric C. Westman, MD, MHS: Vivus: Speakers Bureau; Eisai: Speakers Bureau; KE Diet: Advisory Board; Invoy: Advisory Board; Low Carbohydrate Ketogenic Diet Manual: Royalties; Cholesterol Clarity: Royalties; Keto Clarity: Royalties; Low Carb Adapt Website: Co-founder
  • Nothing to Disclose: Richard David Feinman, PhD; Dana Mansell, CHCP; William McCarthy, MD; Stacy Schmidt, PhD; Laurie Traetow, CAE

 

Formats Available: On-demand
Original Presentation Date: March 29, 2017
On-Demand Release Date: Available Now
More InfoMore Info Treatment of Diabetes (Part 4): Panel Discussion (ARCHIVES)
Collapse Understanding Lipoproteins (ARCHIVES)
Thomas Dayspring, MD, FACP, FNLA, NCMP
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.

 

Description:
The development of atherosclerosis is mediated by lipoproteins. This presentation will cover the role of lipoproteins in lipid metabolism, including which clinical markers are important to assess to determine cardiovascular risk.

 


Disclosures (at time of recording):
Speaker:

  • Thomas Dayspring, MD, FACP, FNLA, NCMP: Health Diagnostic Lab: Consultant; GlaxoSmithKline: Lecture Bureau; Kowa Pharmaceuticals: Consultant

Planners:

  • William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia
  • Craig Primack, MD, FACP, FOMA: Nestle: Speaker, Focus Group Member; VIVUS: Speaker, Consultant; Diet Owl Smart Phone Application: Founder
  • Eric Westman, MD, MHS, MFOMA: VIVUS, Inc.: National Advisory Board and Speaker’s Bureau; KE Diet: Scientific Advisory Board Member
  • Nothing to Disclose: Sandra Christensen, MSN, ARNP, FOMA; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Charles Halliman; Deborah Bade Horn, DO, MPH, MS, MFOMA; Carl Knopke, MD, FOMA; Dana Mansell; Jeremy McConnell, MD, FOMA; Timothy McCormick, DO, MPH; Daisy Merey, MD, PhD; Scott Rigden, MD, FAAFP, MFOMA; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE
Formats Available: On-demand
Original Presentation Date: July 11, 2017
On-Demand Release Date: Available Now
More InfoMore Info Understanding Lipoproteins (ARCHIVES)
Collapse Weight Control: A Question of Calories or Insulin? (ARCHIVES)
Andreas Eenfeldt, MD
*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.


Description:

In Weight Control: A Question of Calories or Insulin?, Dr. Andreas Eenfeldt will delve into the controversies of the energy balance equation, suggesting that "calories consumed" versus "calories burned“ is an oversimplified explanation for how to control weight. The lecture will also discuss how insulin regulates energy balance, including how to address a few of the most common objections to this concept.

 


Disclosures (at time of recording):

Speaker:

  • Andreas Eenfeldt, MD: Nothing to disclose

Planners:

  • William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia

  • Craig Primack, MD, FACP, FOMA: Nestle: Speaker, Focus Group Member; VIVUS: Speaker, Consultant; Diet Owl Smart Phone Application: Founder

  • Nothing to Disclose: Michael Bateman, DO; Crystal Broussard, MD; Sandra Christensen, MSN, ARNP, FOMA; Krishna Doniparthi, MD, FOMA; Brent Gear, DO; Charles Halliman; Deborah Bade Horn, DO, MPH, MFOMA; Carl Knopke, MD, FOMA; Richard Lindquist, MD, ABFM, FAASP, FOMA; Dana Mansell; Jeremy McConnell, MD, FOMA; Timothy McCormick, DO, MPH; Daisy Merey, MD, PhD; Scott Rigden, MD, FAAFP, MFOMA; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE, CPA; J. Warren Willey, DO

Formats Available: Streaming + MP4 Download
Original Presentation Date: June 26, 2017
On-Demand Release Date: Available Now
More InfoMore Info Weight Control: A Question of Calories or Insulin? (ARCHIVES)